cifloxinal 250 mg apvalkotās tabletes
pro.med.cs praha a.s., czech republic - ciprofloksacīns - apvalkotā tablete - 250 mg
dapagliflozin viatris
viatris limited - dapagliflozīns - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - cukura diabēts - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 un 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.
quiflox
krka, d.d., novo mesto, slovēnija - marbofloxacin - tabletes - 20 mg - suņi
quiflox
krka, d.d., novo mesto, slovēnija - marbofloxacin - tabletes - 80 mg - suņi
quiflox
krka, d.d., novo mesto, slovēnija - marbofloxacin - šķīdums injekcijām - 100 mg/ml - cūkas; liellopi
moxifloxacin sandoz 400 mg apvalkotās tabletes
sandoz d.d., slovenia - moksifloksacīns - apvalkotā tablete - 400 mg
boflox flavour
livisto int'l, s.l., spānija - marbofloxacin - tabletes - 20 mg - kaķi; suņi
dapagliflozin polpharma 5 mg apvalkotās tabletes
zaklady farmaceutyczne polpharma s.a., poland - dapagliflozīns - apvalkotā tablete - 5 mg
dapagliflozin polpharma 10 mg apvalkotās tabletes
zaklady farmaceutyczne polpharma s.a., poland - dapagliflozīns - apvalkotā tablete - 10 mg
quiflox
krka, d.d., novo mesto, slovēnija - marbofloxacin - tabletes - 5 mg - kaķi; suņi